National Bank of Canada’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
National Bank of Canada's LLY Position: Q1 2026 in Review
National Bank of Canada reduced its Eli Lilly (LLY) stake by 0.72% in Q1 2026, selling an estimated $4.58M and leaving 620,178 shares worth $570M. The position accounts for 0.51% of the portfolio, ranked #41.
National Bank of Canada first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $817M in Q2 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- National Bank of Canada held 620,178 shares of Eli Lilly worth $570M as of Q1 2026.
- National Bank of Canada sold 4,520 Eli Lilly shares in Q1 2026, an estimated $4.58M.
- Eli Lilly made up 0.51% of National Bank of Canada's portfolio in Q1 2026, its #41 holding.
- National Bank of Canada first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
- National Bank of Canada's Eli Lilly position peaked at $817M in Q2 2025.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.